Hyaluronic Acid Dosage: 60, 100, 120 or 200 mg?

There is no official recommended daily allowance for hyaluronic acid and no single dose has been proven best. Human oral studies have used a surprisingly wide range, from about 60 mg/day to 240 mg/day in modern skin, joint, safety and dry-eye research.

Rather than inventing an “optimal” dose, this guide maps the doses to what was actually studied.

Hyaluronic acid dosage at a glance

Is 120 mg the standard dose?

No, but 120 mg/day appears repeatedly in the skin literature. Major trials include 120 mg/day formulations examining hydration, wrinkles and elasticity. Older work also helped establish 120 mg as an effective studied dose for dry-skin outcomes.

Calling it a “standard” would still be too strong because other successful trials used 60, 100 and 200 mg/day.

What about 200 mg/day?

Two hundred milligrams per day is well within the published evidence range. It appears in modern skin trials and in oral knee-osteoarthritis research.

That makes a 200 mg capsule easy to map to human studies. It does not prove that 200 mg is twice as effective as 100 mg, or better than 120 mg.

Dose-response data are simply not strong enough for that conclusion.

Can 60 mg work?

Yes, depending on formulation and endpoint. A large 2025 trial studied 60 and 120 mg/day of 1.8 MDa sodium hyaluronate in 150 healthy adults. The higher 120 mg dose produced the more consistent skin-aging signal, but the trial demonstrates that modern HA research does not begin at 200 mg.

Skin dosage

For oral skin supplementation, the modern evidence clusters around 60–200 mg/day. Several frequently cited RCTs use 120 mg/day.

If the goal is to choose a product that resembles the clinical literature, a clearly disclosed dose in that range is more defensible than an unspecified proprietary blend.

Read Hyaluronic Acid for Skin for the outcome data behind those doses.

Joint dosage

Several direct joint studies use roughly 111–200 mg/day. Tashiro used 200 mg/day over 12 months; Sugiyama tested 111 mg/day over 12 weeks; another randomized full-spectrum sodium hyaluronate trial used 200 mg/day.

Again, these are studied doses rather than a treatment guideline. Osteoarthritis trials vary substantially in population, product and co-interventions.

Does molecular weight change the required dose?

Potentially, but there is no validated dosing equation that lets you convert molecular weight into a superior clinical dose.

At the same 120 mg/day dose, one trial compared 2 kDa with 300 kDa HA. Another studied 300 and 800 kDa. A later study used 1.8 MDa sodium hyaluronate at 60 and 120 mg/day.

This is why a label claiming “lower molecular weight, so you need less” should be treated as a marketing claim unless that exact formulation has supporting human data.

Should you split the dose?

The major human trials do not establish that split dosing is better than taking the full daily amount at once. Follow the studied product protocol when known, or the manufacturer's directions for a commercial supplement.

Morning or night?

No randomized evidence shows that oral HA works better in the morning or at night. Consistent daily intake is more evidence-aligned than attaching a circadian claim to the supplement.

With food or without food?

There is no strong clinical evidence that HA must be taken with a meal to work. Product instructions vary. If a manufacturer specifies a method, follow it unless your clinician recommends otherwise.

How long should it be taken?

Duration depends on what is being measured:

• Skin: many trials assess 4–12 weeks.
• Joint discomfort: studies range from about 8–12 weeks to 12 months.
• Safety: most controlled data are still short relative to lifelong supplement use.

For skin, evaluating a product after roughly eight to twelve weeks is more consistent with the clinical literature than judging it after a few days.

Is there a maximum safe dose?

The research does not establish a formal tolerable upper intake level for supplemental HA. Studied oral doses should not be converted into a universal maximum.

More is not automatically better. Going far above the human evidence range adds uncertainty without a demonstrated dose-response benefit.

Bottom line

If you want a simple evidence map, 100–200 mg/day captures a large portion of modern oral HA research, while trials extend down to 60 mg and up to 240 mg. Two hundred milligrams is an evidence-consistent dose, not a uniquely proven optimum.

For safety context, see Hyaluronic Acid Side Effects & Safety. For the underlying study records, use the Hyaluronic Acid Research Data Center.